The companion diagnostic launch model is poised to become the go-to method of releasing targeted medications to the public. This approach will not only deepen public satisfaction and trust in your pharmaceutical company but also increase profit margins by targeting your research and development [...]
Financial analysts have good reason to anticipate the continued growth of personalized medicine. Not only is it affecting patients and physicians but it holds plenty of promise for the pharma industry. General Strategic Development Benefits Personalized medicine encourages more vertical [...]
While 2015 was a record year for pharma partnerships, only a fraction of those were focused on commercialization. Competitive pressures are increasing, and pharma launches are becoming less predictable. Gain insight on partnering trends in personalized medicine and solutions for a successful [...]
Companion diagnostics are diagnostic tests that provide information to guide the use of a corresponding therapy. These days, the ‘one therapy fits all’ approach to medicine has been demonstrated to be insufficient. Trial and error is often used to select a therapy for a specific person. [...]
The product launch is a moment of truth when it comes to the longevity of any pharmaceutical company. If a company manages a launch well, all of its recent shortcomings are forgiven and even patent cliffs become less scary. For the companies who will lead the way in the next century, pharmaceutical [...]
When it comes to financial planning in the pharmaceutical industry there are five common mistakes that must absolutely be avoided. To understand how to remedy these mistakes, it helps to realize that one is an overarching problem in pharma financial planning, and the other four are contributing [...]
For the last decade or so, much attention has been focused on personalized medicine; a modern approach that uses an individual’s genetic make-up to create a more targeted therapy or treatment. This advancement in genetics and biochemistry promises to bring to light the factors that explain why [...]
Companion diagnostic services and personalized medicine are quickly revolutionizing the way that drugs are researched, created and marketed. To be prepared for these changes, it’s vital to understand the trends at work in the industry: Here’s what you need to know. 1. Applicability – [...]
As everyone in the industry knows, the pharmaceutical business model is far more complicated than most. It is not simply a case of developing a product, making a cost analysis, researching the competition then bringing the product to market. In pharma, the R&D phase can last 10 to 15 years from [...]
The field of companion diagnostic treatments is still an emerging one and with all things new, preconceived ideas about novel therapeutic approaches and its associated technology can hinder natural acceptance and progress. In addition, a common myth concerning the launch of companion diagnostics [...]